Alto Ingredients (ALTO) Common Equity (2010 - 2026)

Alto Ingredients' Common Equity history runs 17 years deep, the most recent figure standing at $249.9 million for Q1 2026.

• On a quarterly basis, Common Equity rose 16.81% year-over-year to $249.9 million in Q1 2026; TTM through Mar 2026 was $249.9 million, a 16.81% increase from a year earlier, with the FY2025 full-year figure at $245.2 million, up 8.97% from the prior year.
• Common Equity improved to $249.9 million in Q1 2026 per ALTO's latest filing, from $245.2 million in the prior quarter.
• Across five years, Common Equity topped out at $363.6 million in Q2 2022 and bottomed at $207.8 million in Q2 2025.
• The 5-year median for Common Equity is $268.7 million (2024), against an average of $275.6 million.
• Across the five-year window, Common Equity gained 18.04% in 2022 and retreated 21.81% in 2025, its largest moves.
• Year by year, Common Equity stood at $308.1 million in 2022, then slipped by 9.26% to $279.6 million in 2023, then slipped by 19.49% to $225.1 million in 2024, then gained by 8.97% to $245.2 million in 2025, then gained by 1.89% to $249.9 million in 2026.
• Per Business Quant, the three latest ALTO Common Equity figures stand at $249.9 million (Q1 2026), $245.2 million (Q4 2025), and $222.4 million (Q3 2025).